Viewing Study NCT00047294


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-26 @ 12:34 AM
Study NCT ID: NCT00047294
Status: COMPLETED
Last Update Posted: 2017-07-11
First Post: 2002-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module